Stay updated on SAR442168 Dose-finding in MS Clinical Trial
Sign up to get notified when there's something new on the SAR442168 Dose-finding in MS Clinical Trial page.
Latest updates to the SAR442168 Dose-finding in MS Clinical Trial page
- Check4 days agoChange DetectedLocations section reorganized with a new top-level 'Locations' heading and state subsections (Alabama, Florida, Georgia, Illinois, Ohio, Tennessee); the HHS Vulnerability Disclosure notice was removed. The page revision is updated to v3.3.3.SummaryDifference0.5%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2; this is a minor site maintenance change and does not affect study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check33 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Updated the page revision to v3.3.1.SummaryDifference0.1%
- Check41 days agoChange DetectedRemoval of the government funding notice about potential delays and operating status. This does not affect the study details, eligibility criteria, or results listed on the page.SummaryDifference0.2%
- Check55 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03889639; the content appears unchanged.SummaryDifference0.3%
- Check83 days agoChange DetectedUpdated operating-status notice and bumped version from v3.1.0 to v3.2.0, including references to NIH Clinical Center status and relevant HTTP links.SummaryDifference2%
Stay in the know with updates to SAR442168 Dose-finding in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR442168 Dose-finding in MS Clinical Trial page.